Preparation method and application of pyridazinone myocardial perfusion PET radiopharmaceutical

A technology of radiopharmaceuticals and myocardial perfusion, which is applied in the direction of radioactive preparations, radioactive carriers, and pharmaceutical formulations in vivo, and can solve the problems of unclear process flow, unclear applicability of large-scale activity production, and low demand for Fmpp2 activity.
CN112807276AActive Publication Date: 2021-05-18BEIJING SINOTAU INT PHARMA TECH CO LTD
4 Cites 13 Cited by

Patent Information

Authority / Receiving Office
CN Β· China
Patent Type
Applications(China)
Current Assignee / Owner
BEIJING SINOTAU INT PHARMA TECH CO LTD
Publication Date
2021-05-18

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention discloses a preparation method and application of a pyridazinone myocardial perfusion PET radiopharmaceutical. According to the invention, a large-dose initial 18F activity label is adopted, the precursor usage amount of a reaction, the reaction temperature and the purification HPLC condition are optimized, the reaction yield is improved, the preparation amount of [18F]Fmpp2 can reach 200 mCi, the chemical impurity amount is reduced, the radiochemical purity is high, and the key quality index is kept stable within 6 hours. A method for preparing a [18F]Fmpp2 solution for injection is improved, and the radiochemical purity and stability of the [18F]Fmpp2 are improved. The [18F]Fmpp2 prepared by the invention is subjected to miniature pig myocardial model PET imaging display; after the [18F]Fmpp2 is intravenously injected, the myocardial radioactive uptake is high, and the influence of peripheral organs on myocardial development is small; and normal myocardium, ischemic myocardium caused by chronic coronary artery stenosis and infarcted myocardium caused by acute coronary artery stenosis can be distinguished.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the technical field of chemical pharmacy, and in particular relates to a preparation method and application of pyridazinone myocardial perfusion PET radiopharmaceuticals. Background technique

[0002] Radionuclide myocardial perfusion imaging has become the mainstay of stress imaging in the evaluation of patients with suspected or known coronary artery disease (CAD). PET myocardial perfusion imaging can absolutely quantitatively measure myocardial blood flow and blood flow reserve function, and can diagnose coronary heart disease early. It has absolute advantages for patients with microvascular diseases, patients with balanced three-vessel disease, and obese patients.

[0003] [ 18 F] Fmpp2, chemical name 2-tert-butyl-4-chloro-5-((3-((4-((2-(2-fluoro[ 18 F] Ethoxy)ethoxy)methyl)-1H-1,2,3-triazol-1-yl)methyl)benzyl)oxy)pyridazin-3(2H)-one. Chemical Structure:

[0004]

[0005] Molecular formula: C 23 h 29 Cl 18 FN 5 o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More